Invention Grant
- Patent Title: Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
-
Application No.: US15089437Application Date: 2016-04-01
-
Publication No.: US09862952B2Publication Date: 2018-01-09
- Inventor: Anastasia Khvorova , Melissa Moore , Anton A. Turanov , Ananth Karumanchi
- Applicant: University of Massachusetts , BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
- Applicant Address: US MA Boston US MA Boston
- Assignee: UNIVERSITY OF MASSACHUSETTS,BETH ISRAEL DEACONESS MEDICAL CENTER
- Current Assignee: UNIVERSITY OF MASSACHUSETTS,BETH ISRAEL DEACONESS MEDICAL CENTER
- Current Assignee Address: US MA Boston US MA Boston
- Agency: Lathrop Gage LLP
- Agent James H. Velema, Esq.
- Main IPC: A61K31/713
- IPC: A61K31/713 ; C12N15/113
Abstract:
This disclosure relates to novel targets for angiogenic disorders. Novel oligonucleotides are also provided. Methods of using the novel oligonucleotides for the treatment of angiogenic disorders (e.g., preeclampsia) are also provided.
Public/Granted literature
- US20160355826A1 OLIGONUCLEOTIDE COMPOUNDS FOR TREATMENT OF PREECLAMPSIA AND OTHER ANGIOGENIC DISORDERS Public/Granted day:2016-12-08
Information query
